6505--Ropinirole Tablet
Veterans Affairs · NAC PHARMACEUTICALS (36E797)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36E79726R0019 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
Presolicitation Notice Page 1 of Presolicitation Notice Page 1 of 3 Presolicitation Notice *=Required Field Presolicitation Notice Page 4 of 4 DESCRIPTION Presolicitation Notice Presolicitation Notice Page 3 of 3 Presolicitation Notice *=Required Field Presolicitation Notice Page 1 of 3 Page 1 of Page 1 of PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0019 for an unrestrictive procurement for Ropinirole HCLTablets for the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Healt… (show all)
h Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC/UPC number. The standard package unit of use is bottles. Solicitation #36E79726R0019 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about April 23, 2026, with a tentative closing date� of May 07, 2026. The NAICS code for this procurement is� 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: www.beta.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Michael Olszewski. Questions can be e-mailed to:� Michael.Olszewski@va.gov. The estimated annual requirements are as follows: ITEM DESCRIPTION PACKAGE SIZE (Tablets per Bottle) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 ROPINIROLE HCL 0.25MG TAB 100 20,608 2 ROPINIROLE HCL 0.25MG TAB 500 7,335 3 ROPINIROLE HCL 0.5MG TAB 100 25,269 4 ROPINIROLE HCL 0.5MG TAB 500 10,332 5 ROPINIROLE HCL 1MG TAB 100 33,807 6 ROPINIROLE HCL 1MG TAB 500 12,384 7 ROPINIROLE HCL 2MG TAB 100 16,075 8 ROPINIROLE HCL 2MG TAB 500 8,029 9 ROPINIROLE HCL 3MG TAB 100 4,853 10 ROPINIROLE HCL 3MG TAB 500 2,835 11 ROPINIROLE HCL 4MG TAB 100 4,153 12 ROPINIROLE HCL 4MG TAB 500 2,924 13 ROPINIROLE HCL 5MG TAB 100 4,549
Who won similar work
78 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 325412.
| Winner | Awards | Value | Last |
|---|---|---|---|
| GOLDEN STATE MEDICAL SUPPLY, INC. | 26 | $320.5M | Sep 15, 2026 |
| EXELAN PHARMACEUTICALS INC | 7 | $209.8M | Mar 5, 2026 |
| XLCARE PHARMACEUTICALS INC | 6 | $144.4M | Mar 9, 2026 |
| AVKARE LLC | 6 | $134.0M | Jul 22, 2026 |
| RADHA PHARMACEUTICALS INC | 6 | $69.3M | Apr 17, 2026 |
| PFIZER INC · $PFE | 2 | $120.9M | Apr 29, 2025 |
| SEQIRUS USA INC | 2 | $82.6M | Dec 15, 2025 |
| DR REDDY'S LABORATORIES, INC. · $RDY | 2 | $38.9M | Jan 9, 2026 |
| MARLEX PHARMACEUTICALS INC | 2 | $10.3M | May 22, 2026 |
| SANOFI PASTEUR INC. | 2 | $8.8M | Dec 15, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Sep 15, 2026GOLDEN STATE MEDICAL SUPPLY, INC.$26.6M6505--Mesalamine 1200mg Tablet (VA-27-00000768)
- Aug 26, 2026GOLDEN STATE MEDICAL SUPPLY, INC.$10.8M6505--Diltiazem SA Capsules (AB3)
- Aug 19, 2026GOLDEN STATE MEDICAL SUPPLY, INC.$9.6M6505--Esomeprazole Magnesium Capsules Effective 10/19/2026 - 10/18/2027
- Jul 24, 2026MYLAN PHARMACEUTICALS INC$436.5M6505--Budesonide/Formoterol INH
- Jul 22, 2026AVKARE LLC$1.9M6505--Famciclovir Tablets
- Jul 22, 2026ANIP ACQUISITION CO BAUDETTE 56623$3.7M6505--Benazepril HCL Tablets
- Jun 25, 2026PURACAP LABORATORIES LLC$32.4M6505--PuraCap Contract Award Venlafaxine 24HR SA Capsules
- May 22, 2026MARLEX PHARMACEUTICALS INC$5.9M6505--Melatonin Tablets Effective 09/15/26 - 09/14/27
- May 19, 2026AVKARE LLC$2.0M6505--Montelukast NA Chewable Tablets Effective August 09, 2026 to August 08, 2027
- May 7, 2026GOLDEN STATE MEDICAL SUPPLY, INC.$21.0M6505--Buprenorphine Award
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $61K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 2 of the past winners are listed companies
- 3 insider buys and 1 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.